Analysis
PublicTHE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. holds $103.5M across 50 federal awards, concentrated at Department of Defense (DOD). The prior award was single-bid — competitive dynamics may favor a challenge. Set-aside status: NONE. Recompete timing centers on the Sep 29, 2026 PoP end — agencies typically plan 12–18 months ahead.
Contract facts
NONEMENINGOCOCCAL IMMUNIZATION AGAINST GONOCOCCAL INFECTION (MAGI) TRIAL/ RV564
Recompete timing
PublicCurrent PoP ends Sep 29, 2026 (43 days remaining). Agencies typically plan 12–18 months ahead — at 1.4 months out, that window is already open. The buying decision is likely already in motion.
Watch this contract — one email →Incumbent footprint
Public recordTHE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. — $103.5M obligated across 50 awards (firm-wide, all agencies) · lead buyer Department of Defense (DOD).
Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Track this contract
Get an alert when the recompete window opens, the incumbent changes, or a protest lands. One email, no account.
Alert when the recompete window opens, the incumbent changes, or a protest lands. One email, no account.
See all live recompete landscapes — who else is expiring, and where the openings are.
Open THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC.’s federal contract profile — agency mix, recompete pipeline, and teaming relationships.
Frequently asked questions
What is contract HU000125CE001?
HU000125CE001 (MENINGOCOCCAL IMMUNIZATION AGAINST GONOCOCCAL INFECTION (MAGI) TRIAL/ RV564) is a Department of Defense (DOD) award with an estimated value of $1.2M, currently held by THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC.. Figures are USASpending-sourced public-record facts normalized by PrimeRFP SCOUT.
Who is the incumbent on HU000125CE001?
THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. is the incumbent with $103.5M across 50 related awards in SCOUT’s public footprint. The current period of performance ends Sep 29, 2026.
When does HU000125CE001 come up for recompete?
SCOUT tracks a period-of-performance end of Sep 29, 2026. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows. Explore it live — $90 Pilot →